Immunological Mechanisms of Autoimmune Thyroid Diseases: A Shift in The Traditional TH1/TH2 Paradigm

Aghini Lombardi, F., Fiore, E., Tonacchera, M., Antonangeli, L., Rago, T., Frigeri, M., Provenzale, A. M., Montanelli, L., Grasso, L., Pinchera, A., Vitti, P. (2013). The effect of voluntary iodine prophylaxis in a small rural community: The pescopagano survey 15 years later. J. Clin. Endocrin. Metab., 98, 1031–1039.10.1210/jc.2012-296023436921Search in Google Scholar

Anonymous (2018). Statistics on medicines consumption 2017. State Agency of Medicines. Available from: https://www.zva.gov.lv/sites/default/files/2018-05/zva-zstat-2017.pdf (accessed 15 June 2018).Search in Google Scholar

Badenhoop, K., Schwarz, G., Walfish, P. G., Drummond, V., Usadel, K. H., Bottazzo, G. F. (1990). Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto’s thyroiditis. J. Clin. Endocrin. Metab., 71 (5), 1131–1137.10.1210/jcem-71-5-11311977755Search in Google Scholar

Berger, A. (2000). Th1 and Th2 responses: What are they? BMJ, 321, 424.10.1136/bmj.321.7258.4242745710938051Search in Google Scholar

Bliddal, S., Borresen, S. W., Feldt-Rasmussen, U. (2017). Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis. Front Endocrinol., 8, 179.10.3389/fendo.2017.00179553447028824542Search in Google Scholar

Bossowski, A., Moniuszko, M., Idźkowska, E., Dąbrowska, M., Jeznach, M., Sawicka, B., Borysewicz-Sańczyk, H., Bossowska, A., Rusak, M., Bodzenta-Łukaszyk, A. (2012) Evaluation of CD4+CD161+CD196+ and CD4+IL-17+ Th17 cells in the peripheral blood of young patients with Hashimoto’s thyroiditis and Graves’ disease. Pediatr Endocrinol Diabetes Metab, 18, 89–95 (in Polish).Search in Google Scholar

Brix, T. H., Kyvik, K. O., Christensen, K., Hegedüs, L. (2001). Evidence for a major role of heredity in Graves’ disease: A population-based study of two Danish twin cohorts. J. Clin. Endocrin. Metab., 86, 930–934.10.1210/jc.86.2.930Search in Google Scholar

Brix, T. H., Kyvik, K. O., Hegedüs, L. (2000). A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrin. Metab., 85, 536–539.10.1210/jc.85.2.536Search in Google Scholar

Carayanniotis, G. (2011). Molecular parameters linking thyroglobulin iodination with autoimmune thyroiditis. Hormones, 10 (1), 27–35.10.14310/horm.2002.129021349803Search in Google Scholar

Carlé, A., Pedersen, I. B., Knudsen, N., Perrild, H., Ovesen, L., Rasmussen, L. B., Laurberg, P. (2011). Epidemiology of subtypes of hyperthyroidism in Denmark: A population-based study. Eur. J. Endocrinol., 164 (5), 801–809.10.1530/EJE-10-115521357288Search in Google Scholar

Carvalho, G. A. de, Perez, C. L. S., Ward, L. S. (2013). The clinical use of thyroid function tests. Arquivos Brasil. Endocrinol. Metab., 57, 193–204.10.1590/S0004-2730201300030000523681265Search in Google Scholar

Chang, L. S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., Min, L. (2019). Endocrine toxicity of cancer immunotherapy targeting immune checkpoints, Endocr. Rev., 40, 17–6510.1210/er.2018-00006Search in Google Scholar

Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J. M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., Rudensky, A. Y. (2011). Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity, 34, 566–578.10.1016/j.immuni.2011.03.018308848521511185Search in Google Scholar

Chrousos, G. P., Elenkov, I. J. (2006). Interactions of the endocrine and immune systems. In: DeGroot, L. J., Jameson, J. L. (eds.). Endocrinology. Saunders Elsevier, Philadelphia, PA, pp. 799–818.Search in Google Scholar

Combs, G. F. (2015). Biomarkers of selenium status. Nutrients, 7, 2209–2236.10.3390/nu7042209Search in Google Scholar

Cooper, G., Stroehla, B. (2003). The epidemiology of autoimmune diseases. Autoimmun. Rev.,2, 119–125.10.1016/S1568-9972(03)00006-5Search in Google Scholar

Croxford, A. L., Mair, F., Becher, B. (2012). IL-23: One cytokine in control of autoimmunity. Eur. J. Immunol., 42, 2263–2273.10.1002/eji.20124259822949325Search in Google Scholar

Dittmar, M., Libich, C., Brenzel, T., Kahaly, G. J. (2011). Increased familial clustering of autoimmune thyroid diseases. Hormone Metab. Res., 43 (3), 200–204.10.1055/s-0031-127161921287436Search in Google Scholar

Effraimidis, G., Strieder, T. G. A., Tijssen, J. G. P., Wiersinga, W. M. (2011). Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: A prospective study. Eur. J. Immunol., 164, 107–113.10.1530/EJE-10-078520956436Search in Google Scholar

Effraimidis, G., Wiersinga, W. M. (2014). Mechanisms in endocrinology: Autoimmune thyroid disease: Old and new players. Eur. J. Immunol., 170(6), R241–R252.10.1530/EJE-14-004724609834Search in Google Scholar

Fang, S., Huang, Y., Zhong, S., Li, Y., Zhang, Y., Li, Y., Sun, J., Liu, X., Wang, Y., Zhang, S., Xu, T., Sun, X., Gu, P., Li, D., Zhou, H., Li, B., Fan, X. (2017). Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in Graves orbitopathy, J. Clin. Endocrinol. Metab., 102, 4273–428310.1210/jc.2017-0134928938397Search in Google Scholar

Fasching, P., Stradner, M., Graninger, W., Dejaco, C., Fessler, J. (2017). Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules, 22, 134.10.3390/molecules22010134615588028098832Search in Google Scholar

Figueroa-Vega, N., Alfonso-Pérez, M., Benedicto, I., Sánchez-Madrid, F., González-Amaro, R., Marazuela, M. (2010). Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab., 95, 953–962.10.1210/jc.2009-171920016049Search in Google Scholar

Fröhlich, E., Wahl, R. (2017). Thyroid autoimmunity: Role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Frontiers Immunol., 8, 521.10.3389/fimmu.2017.00521542247828536577Search in Google Scholar

Ghoreschi, K., Laurence, A., Yang, X. P., Tato, C. M., McGeachy, M. J., Konkel, J. E., O’Shea, J. J. (2010). Generation of pathogenic TH17 cells in the absence of TGF-β2 signalling. Nature, 467, 967–971.10.1038/nature09447310806620962846Search in Google Scholar

Glick, A. B., Wodzinski, A., Fu, P., Levine, A. D., Wald, D. N. (2013). Impairment of regulatory T-Cell function in autoimmune thyroid disease. Thyroid, 23, 871–878.10.1089/thy.2012.0514370410623379353Search in Google Scholar

González-Amaro, R., Marazuela, M. (2016). T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine, 52 (1), 30–38.10.1007/s12020-015-0759-726475497Search in Google Scholar

Han, Y., Guo, Q., Zhang, M., Chen, Z., Cao, X. (2009). CD69+CD4+CD25-T Cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-β1. J. Immunol., 182, 111–120.10.4049/jimmunol.182.1.11119109141Search in Google Scholar

Hansen, P. S., Brix, T. H., Iachine, I., Kyvik, K. O., Hegedüs, L. (2006). The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: A study of healthy Danish twins. Eur. J. Endocrinol., 154, 29–38.10.1530/eje.1.0206016381988Search in Google Scholar

Hansen, P. S., Brix, T. H., Iachine, I., Kyvik, K. O., Hegedüs, L. (2006). The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: A study of healthy Danish twins. Eur. J. Endocrinol., 154, 29–38.10.1530/eje.1.02060Search in Google Scholar

Harpaz, I., Abutbul, S., Nemirovsky, A., Gal, R., Cohen, H., Monsonego, A. (2013). Chronic exposure to stress predisposes to higher autoimmune susceptibility in C57BL/6 mice: Glucocorticoids as a double-edged sword. Eur. J. Immunol., 43 (3), 758–769.10.1002/eji.20124261323255172Search in Google Scholar

Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., Braverman, L. E. (2002). Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab., 87 (2), 489–499.10.1210/jcem.87.2.818211836274Search in Google Scholar

Hu, S., Rayman, M. P. (2017). Multiple nutritional factors and the risk of Hashimoto’s thyroiditis. Thyroid, 27 (5), 597–610.10.1089/thy.2016.063528290237Search in Google Scholar

Huber, S., Gagliani, N., Esplugues, E., O’Connor, W., Huber, F. J., Chaudhry, A., Kamanaka, M., Kobayashi, Y., Booth, C. J., Rudensky, A. Y., Roncarolo, M. G., Battaglia, M., Flavell, R. A. (2011). Th17 cells express interleukin-10 receptor and are controlled by Foxp3– and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity, 34 (3), 554–565.10.1016/j.immuni.2011.01.020311361721511184Search in Google Scholar

Iyer, P. C., Cabanillas, M. E., Waguespack, S. G., Hu, M. I., Thosani, S., Lavis, V. R., Busaidy, N. L., Subudhi, S. K., Diab, A., Dadu, R. (2018). Immune-related thyroiditis with immune checkpoint inhibitors. Thyroid, 28, 1243–1251.10.1089/thy.2018.0116615735930132401Search in Google Scholar

Katagiri, R., Yuan, X., Kobayashi, S., Sasaki, S. (2017). Effect of excess iodine intake on thyroid diseases in different populations: A systematic review and meta-analyses including observational studies. PLoS one,12 (3), e0173722.10.1371/journal.pone.0173722534585728282437Search in Google Scholar

Khong, J. J., Goldstein, R. F., Sanders, K. M., Schneider, H., Pope, J., Burdon, K. P., Craig, J. E., Ebeling, P. R. (2014). Serum selenium status in Graves’ disease with and without orbitopathy: A case-control study. Clinical Endocrinology, 80 (6), 905–910.10.1111/cen.1239224372054Search in Google Scholar

Kim, S. E., Yoon, J. S., Kim, K. H., Lee, S. Y. (2012). Increased serum interleukin-17 in Graves’ ophthalmopathy. Graefes Arch. Clin. Exp. Ophthalmol., 250, 1521–1526.10.1007/s00417-012-2092-7Search in Google Scholar

Konca Degertekin, C., Aktas Yilmaz, B., Balos Toruner, F., Kalkanci, A., Turhan Iyidir, O., Fidan, I., Yesilyurt, E., Cakir, N., Kustimur, S., Arslan, M. (2016). Circulating Th17 cytokine levels are altered in Hashimoto’s thyroiditis. Cytokine, 80, 13–17.10.1016/j.cyto.2016.02.01126928603Search in Google Scholar

Konrade, I., Kalere, I., Strele, I., Makrecka-Kuka, M., Jekabsone, A., Tetere, E., Veisa, V., Gavars, D., Rezeberga, D., Pīrāgs, V., Lejnieks, A., Dambrova, M. (2015). Iodine deficiency during pregnancy: A national cross-sectional survey in Latvia. Publ. Health Nutr.,18 (16), 2990–2997.10.1017/S136898001500046425731595Search in Google Scholar

Kristensen, B., Hegedüs, L., Lundy, S. K., Brimnes, M. K., Smith, T. J., Nielsen, C. H. (2015). Characterization of regulatory B cells in Graves’ disease and Hashimoto’s thyroiditis. PLoS one,10 (5), e0127949.10.1371/journal.pone.0127949444633526016954Search in Google Scholar

Latina, A., Gullo, D., Trimarchi, F., Benvenga, S. (2013). Hashimoto’s thyroiditis: Similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PloS one, 8(3), e55450.10.1371/journal.pone.0055450Search in Google Scholar

Lee, H. J., Li, C. W., Hammerstad, S. S., Stefan, M., Tomer, Y. (2015). Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J. Autoimmun., 64, 82–90.10.1016/j.jaut.2015.07.009462884426235382Search in Google Scholar

Li, C., Yuan, J., Zhu, Y. F., Yang, X. J., Wang, Q., Xu, J., He, S. T., Zhang, J. A. (2016). Imbalance of Th17/Treg in different subtypes of autoimmune thyroid diseases. Cell. Physiol. Biochem., 40 (1–2), 245–252.10.1159/00045254127855396Search in Google Scholar

Li, D., Cai, W., Gu, R., Zhang, Y., Zhang, H., Tang, K., Xu, P., Katirai, F., Shi, W., Wang, L., Huang, T., Huang, B. (2013). Th17 cell plays a role in the pathogenesis of Hashimoto’s thyroiditis in patients. Clin. Immunol.,149, 411–420.10.1016/j.clim.2013.10.00124211715Search in Google Scholar

Maddur, M. S., Miossec, P., Kaveri, S. V., Bayry, J. (2012). Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Amer. J. Pathol., 181 (1), 8–18.10.1016/j.ajpath.2012.03.04422640807Search in Google Scholar

Maldonado, R. A., von Andrian, U. H. (2010). How tolerogenic dendritic cells induce regulatory T cells. Adv. Immunol., 108, 111–165.10.1016/B978-0-12-380995-7.00004-5Search in Google Scholar

Mandac, J. C., Chaudhry, S., Sherman, K. E., Tomer, Y. (2006). The clinical and physiological spectrum of interferon-alpha induced thyroiditis: Toward a new classification. Hepatology, 43, 661–672.10.1002/hep.21146Search in Google Scholar

Mao, C., Wang, S., Xiao, Y., Xu, J., Jiang, Q., Jin, M., Jiang, X., Guo, H., Ning, G., Zhang, Y. (2011). Impairment of regulatory capacity of CD4+CD25+ regulatory T cells mediated by dendritic cell polarization and hyperthyroidism in Graves’ disease. J. Immunol., 186 (8), 4734–4743.10.4049/jimmunol.0904135Search in Google Scholar

Markou, K., Georgopoulos, N., Kyriazopoulou, V., Vagenakis, A. G. (2001). Iodine-Induced hypothyroidism. Thyroid, 11, 501–510.10.1089/105072501300176462Search in Google Scholar

McInnes, I. B., Mease, P. J., Kirkham, B., Kavanaugh, A., Ritchlin, C. T., Rahman, P., Mpofu, S. (2015). Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): A randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 386, 1137–1146.10.1016/S0140-6736(15)61134-5Search in Google Scholar

Miranda, D. M. C., Massom, J. N., Catarino, R. M., Santos, R. T. M., Toyoda, S. S., Marone, M. M. S., Monte, O. (2015). Impact of nutritional iodine optimization on rates of thyroid hypoechogenicity and autoimmune thyroiditis: A cross-sectional, comparative study. Thyroid, 25, 118–124.10.1089/thy.2014.018225314342Search in Google Scholar

Morris, G. P., Brown, N. K., Kong, Y. C. (2009). Naturally-existing CD4+CD25+Foxp3+regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J. Autoimmun., 33 (1), 68–76.10.1016/j.jaut.2009.03.010270609719375891Search in Google Scholar

Morshed, S. A., Latif, R., Davies, T. F. (2012). Delineating the autoimmune mechanisms in Graves’ disease. Immunol. Res., 54, 191–203.10.1007/s12026-012-8312-8450418222434518Search in Google Scholar

Papp, G., Boros, P., Nakken, B., Szodoray, P., Zeher, M. (2017). Regulatory immune cells and functions in autoimmunity and transplantation immunology. Autoimmun. Rev., 16 (5), 435–444.10.1016/j.autrev.2017.03.01128286106Search in Google Scholar

Paschou, S. A., Palioura, E., Kothonas, F., Myroforidis, A., Loi, V., Poulou, A., Goumas, K., Effraimidis, G., Vryonidou, A. (2018). The effect of anti-TNF therapy on thyroid function in patients with inflammatory bowel disease. Endocr. J., 65, 1121–1125.10.1507/endocrj.EJ18-024330135331Search in Google Scholar

Peck, A., Mellins, E. D. (2010). Plasticity of T-cell phenotype and function: The T helper type 17 example. Immunology, 129, 147–153.10.1111/j.1365-2567.2009.03189.xSearch in Google Scholar

Pedersen, I. B., Knudsen, N., Carlé, A., Schomburg, L., Köhrle, J., Jørgensen, T., Rasmussen, L. B., Ovesen, L., Laurberg, P. (2013). Serum selenium is low in newly diagnosed Graves’ disease: A population-based study. Clin. Endocrinol.,79, 584–590.10.1111/cen.12185Search in Google Scholar

Pedersen, I. B., Knudsen, N., Carlé, A., Vejbjerg, P., Jørgensen, T., Perrild, H., Laurberg, P. (2011). A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin. Endocrinol., 75, 120–126.10.1111/j.1365-2265.2011.04008.xSearch in Google Scholar

Pedersen, I. B., Laurberg, P., Knudsen, N., Jørgensen, T., Perrild, H., Ovesen, L., Rasmussen, L. B. (2007). An increased incidence of overt hypothyroidism after iodine fortification of salt in Denmark: A prospective population study. J. Clin. Endocrinol. Metab., 92, 3122–3127.10.1210/jc.2007-0732Search in Google Scholar

Pyzik, A., Grywalska, E., Matyjaszek-Matuszek, B., Roliński, J. (2015). Immune disorders in Hashimoto’s thyroiditis: what do we know so far? J. Immunol. Res.,2015, 979167.10.1155/2015/979167Search in Google Scholar

Qin, H., Wang, L., Feng, T., Elson, C. O., Niyongere, S. A., Lee, S. J., Reynolds, S. L., Weaver, C. T., Roarty, K., Serra, R., Benveniste, E. N., Cong, Y. (2009). TGF-β promotes Th17 cell development through inhibition of SOCS3. J. Immunol., 183, 97–105.10.4049/jimmunol.0801986Search in Google Scholar

Qin, Q., Liu, P., Liu, L., Wang, R., Yan, N., Yang, J., Wang, X., Pandey, M., Zhang, J. A. (2012). The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto’s thyroiditis but not in Graves’ disease. Brazilian J. Med. Biol. Res., 45, 1202–1208.10.1590/S0100-879X2012007500168Search in Google Scholar

Ramos-Leví, A. M., Marazuela, M. (2016). Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinología y Nutrición, 63, 421–429.10.1016/j.endonu.2016.04.003Search in Google Scholar

Rayman, M. P. (2012). Selenium and human health. The Lancet, 379, 1256–1268.10.1016/S0140-6736(11)61452-9Search in Google Scholar

Rebuffat, S. A., Nguyen, B., Robert, B., Castex, F., Peraldi-Roux, S. (2008). Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 93, 929–934.10.1210/jc.2007-204218073303Search in Google Scholar

Rodríguez-Muñoz, A., Vitales-Noyola, M., Ramos-Levi, A., Serrano-Somavilla, A., González-Amaro, R., Marazuela, M. (2016). Levels of regulatory T cells CD69+NKG2D+IL-10+are increased in patients with autoimmune thyroid disorders. Endocrine, 51, 478–489.10.1007/s12020-015-0662-226100786Search in Google Scholar

Roncarolo, M. G., Gregori, S., Bacchetta, R., Battaglia, M. (2014). Tr1 cells and the counter-regulation of immunity: Natural mechanisms and therapeutic applications. Curr. Topics Microbiol. Immunol.,380, 39–68.10.1007/978-3-662-43492-5_325004813Search in Google Scholar

Roura-Mir, C., Catálfamo, M., Cheng, T.-Y., Marqusee, E., Besra, G. S., Jaraquemada, D., Moody, D. B. (2005). CD1a and CD1c activate intrathyroidal T cells during Graves’ disease and Hashimoto’s thyroiditis. J. Immunol.,174, 3773–3780.10.4049/jimmunol.174.6.377315749918Search in Google Scholar

Salmaso, C., Bagnasco, M., Pesce, G., Montagna, P., Brizzolara, R., Altrinetti, V., Giordano, C. (2002). Regulation of apoptosis in endocrine autoimmunity: Insights from Hashimoto’s thyroiditis and Graves’ disease. Ann. New York Acad. Sci.,966, 496–501.10.1111/j.1749-6632.2002.tb04253.x12114310Search in Google Scholar

Shevach, E. M. (2006). From vanilla to 28 flavors: Multiple varieties of T regulatory cells. Immunity, 25 (2), 195–201.10.1016/j.immuni.2006.08.00316920638Search in Google Scholar

Shevach, E. M., Thornton, A. M. (2014). tTregs, pTregs, and iTregs: Similarities and differences. Immunol Rev, 259, 88–102.10.1111/imr.12160398218724712461Search in Google Scholar

Song, X., Gao, H., Qian, Y. (2014). Th17 differentiation and their proinflammation function. Adv. Exper. Med. Biol., 841, 99–151.10.1007/978-94-017-9487-9_525261206Search in Google Scholar

Stadhouders, R., Lubberts, E., Hendriks, R. W. (2018). A cellular and molecular view of T helper 17 cell plasticity in autoimmunity. J. Autoimmun., 87, 1–15.10.1016/j.jaut.2017.12.00729275836Search in Google Scholar

Stritesky, G. L., Yeh, N., Kaplan, M. H. (2008). IL-23 promotes maintenance but not commitment to the Th17 lineage. J. Immunol., 181, 5948–5955.10.4049/jimmunol.181.9.5948267890518941183Search in Google Scholar

Teng, W., Shan, Z., Teng, X., Guan, H., Li, Y., Teng, D., Li, C. (2006). Effect of iodine intake on thyroid diseases in China. New England J. Med., 354, 2783–2793.10.1056/NEJMoa05402216807415Search in Google Scholar

Tomer, Y. (2014). Mechanisms of autoimmune thyroid diseases: From genetics to epigenetics. Annu. Rev. Pathol.,9, 147–156.10.1146/annurev-pathol-012513-104713412863724460189Search in Google Scholar

Tomer, Y., Davies, T. F. (2003). Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr. Rev., 24, 694–717.10.1210/er.2002-003014570752Search in Google Scholar

Tomer, Y., Huber, A. (2009). The etiology of autoimmune thyroid disease: A story of genes and environment. J. Autoimmun., 87 (1), 404–407.10.1016/j.jaut.2009.02.007356149419307103Search in Google Scholar

Toulis, K. A., Anastasilakis, A. D., Tzellos, T. G., Goulis, D. G., Kouvelas, D. (2010). Selenium supplementation in the treatment of Hashimoto’s thyroiditis: A systematic review and a meta-analysis. Thyroid, 20, 1163–1173.10.1089/thy.2009.035120883174Search in Google Scholar

Valea, A., Georgescu, C. E. (2018). Selenoproteins in human body: focus on thyroid pathophysiology. Hormones, 17, 183–196.10.1007/s42000-018-0033-529873029Search in Google Scholar

Villanueva, R., Greenberg, D. A., Davies, T. F., Tomer, Y. (2003). Sibling recurrence risk in autoimmune thyroid disease. Thyroid, 13, 761–764.10.1089/10507250376849965314558919Search in Google Scholar

Vita, R., Lapa, D., Trimarchi, F., Benvenga, S. (2014). Stress triggers the onset and the recurrences of hyperthyroidism in patients with Graves’ disease. Endocrine, 48 (1), 254–263.10.1007/s12020-014-0289-8Search in Google Scholar

Weetman, A. P. (2010). Immunity, thyroid function and pregnancy: Molecular mechanisms. Nature Rev. Endocrinol., 6 (6), 311–318.10.1038/nrendo.2010.4620421883Search in Google Scholar

Wichman, J., Winther, K. H., Bonnema, S. J., Hegedüs, L. (2016). Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis. Thyroid, 26 (12), 1681–1692.10.1089/thy.2016.025627702392Search in Google Scholar

Winther, K. H., Wichman, J. E. M., Bonnema, S. J., Hegedüs, L. (2017). Insufficient documentation for clinical efficacy of selenium supplementation in chronic autoimmune thyroiditis, based on a systematic review and meta-analysis. Endocrine, 55 (2), 376–385.10.1007/s12020-016-1098-z527287727683225Search in Google Scholar

Wu, Q., Rayman, M. P., Lv, H., Schomburg, L., Cui, B., Gao, C., Chen, P., Zhuang, G., Zhenan, Z., Peng, X., Li, H., Zhao, Y., He, X., Zeng, G., Qin, F., Hou, P., Shi, B. (2015). Low population selenium status is associated with increased prevalence of thyroid disease. J. Clin. Endocrinol. Metab., 100, 4037–4047.10.1210/jc.2015-222226305620Search in Google Scholar

Xiong, H., Wu, M., Yi, H., Wang, X., Wang, Q., Nadirshina, S., Zhou, X., Liu, X. (2016). Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis. Sci. Rep.6, 30356.10.1038/srep30356Search in Google Scholar

Xu, C., Wu, F., Mao, C., Wang, X., Zheng, T., Bu, L., Xiao, Y. (2016). Excess iodine promotes apoptosis of thyroid follicular epithelial cells by inducing autophagy suppression and is associated with Hashimoto thyroiditis disease. J. Autoimmun.,75, 50–57.10.1016/j.jaut.2016.07.008Search in Google Scholar

Xue, H., Wang, W., Li, Y., Shan, Z., Li, Y., Teng, X., Gao, Y., Fan, C., Teng, W. (2010). Selenium upregulates CD4(+)CD25(+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr. J., 57 (7), 595–601.10.1507/endocrj.K10E-063Search in Google Scholar

Yu, X., Li, L., Li, Q., Zang, X., Liu, Z. (2011). TRAIL and DR5 promote thyroid follicular cell apoptosis in iodine excess-induced experimental autoimmune thyroiditis in NOD mice. Biol. Trace Element Res., 143, 1064–1076.10.1007/s12011-010-8941-5Search in Google Scholar

Zake, T., Skuja, S., Kalere, I., Konrade, I., Groma, V. (2018). Heterogeneity of tissue IL-17 and tight junction proteins expression demonstrated in patients with autoimmune thyroid diseases. Medicine, 97, e11211.10.1097/MD.0000000000011211Search in Google Scholar

Zeitlin, A. A., Heward, J. M., Newby, P. R., Carr-Smith, J. D., Franklyn, J. A., Gough, S. C. L., Simmonds, M. J. (2008). Analysis of HLA class II genes in Hashimoto’s thyroiditis reveals differences compared to Graves’ disease. Genes Immun., 9 (4), 358–363.10.1038/gene.2008.26Search in Google Scholar

Zimmermann, M. B., Boelaert, K. (2015). Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol., 3, 286–295.10.1016/S2213-8587(14)70225-6Search in Google Scholar